药物对比
Galcanezumab vs Methysergide
比较 Galcanezumab (Emgality) 与 Methysergide 在偏头痛预防方面的应用。CGRP阻断 vs 5-羟色胺拮抗的差异，以及安全性和给药方式的差异。
此页面暂无可用的对比维度。
临床背景
This comparison arises when patients with frequent migraines evaluate older oral prophylactics against modern injectable CGRP inhibitors.
结论
Galcanezumab represents a safer, evidence-based alternative to the largely obsolete Methysergide for migraine prevention.
全部药物对比